BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 140959)

  • 1. [The investigation of a low molecular acid stable proteinase inhibitor in the middle ear secretion (author's transl)].
    Kastenbauer ER; Hochstrasser K; Reichert R; Brohr T
    Laryngol Rhinol Otol (Stuttg); 1977 Mar; 56(3):201-6. PubMed ID: 140959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experimental investigations on the proportional inhibitory capacity of different proteinase inhibitors in cases of chronic otitis media and cholesteatoma (author's transl)].
    Kastenbauer ER; Hochstrasser K
    Laryngol Rhinol Otol (Stuttg); 1978 Oct; 57(10):869-71. PubMed ID: 82895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental studies on the reaction of the immunological system during chronic otitis media and about the course of this disease (author's transl)].
    Kastenbauer ER; Hochstrasser K
    Laryngol Rhinol Otol (Stuttg); 1976 Jan; 55(1):36-42. PubMed ID: 60682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of ear surgery to the immunologic defense system of the middle ear during chronic otitis media (author's transl)].
    Kastenbauer ER; Hochstrasser K; Brohr T
    Laryngol Rhinol Otol (Stuttg); 1976 Oct; 55(10):804-12. PubMed ID: 63098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection of split products of the immunoglobulins IgG, IgA and IgM during chronic otitis media (author's transl)].
    Kastenbauer ER; Hochgesand K; Hochstrasser K; Tappermann G
    Laryngol Rhinol Otol (Stuttg); 1975 Jul; 54(7):604-11. PubMed ID: 129630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experimental studies on the question of the enzymatic destruction of the ossicular bones during middle ear inflammations (author's transl)].
    Hochgesand K; Kastenbauer E; Hochstrasser K
    Laryngol Rhinol Otol (Stuttg); 1976 Mar; 55(3):206-9. PubMed ID: 135146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Enzymatic and immunological inflammatory reactions in the middle ear (author's transl)].
    Kastenbauer ER
    Laryngol Rhinol Otol (Stuttg); 1975 Mar; 54(3):177-82. PubMed ID: 123983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protease inhibitors in middle ear effusions from experimental otitis media with effusion: kinetics of alpha 1-antitrypsin and alpha 2-macroglobulin levels.
    Hamaguchi Y; Juhn SK; Sakakura Y
    Ann Otol Rhinol Laryngol; 1989 Apr; 98(4 Pt 1):287-92. PubMed ID: 2468303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical study of protease inhibitors in experimental otitis media with effusion.
    Juhn SK; Hamaguchi Y
    Ann Otol Rhinol Laryngol Suppl; 1988; 132():10-3. PubMed ID: 2454602
    [No Abstract]   [Full Text] [Related]  

  • 10. Protease inhibitors in middle ear effusions.
    Carlsson B; Lundberg C; Ohlsson K
    Ann Otol Rhinol Laryngol; 1981; 90(1 Pt 1):38-41. PubMed ID: 6162410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of protease activity in human otitis media.
    Avidano MA; Cotter CS; Stringer SP; Schultz GS
    Otolaryngol Head Neck Surg; 1998 Oct; 119(4):346-51. PubMed ID: 9781988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of antileukoprotease in middle ear mucosa.
    Carlsson B; Ohlsson K
    Acta Otolaryngol; 1983; 95(1-2):111-6. PubMed ID: 6829291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The significance of protease inhibitors in the pathogenesis of otitis media with effusion.
    Hamaguchi Y; Majima Y; Ukai K; Sakakura Y; Miyoshi Y
    Auris Nasus Larynx; 1985; 12 Suppl 1():S145-7. PubMed ID: 3835890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Carcinoembryonic antigen in chronic otitis media with cholesteatoma].
    Sanković-Babić S; Sofronić-Milosavljević Lj
    Srp Arh Celok Lek; 2000; 128(3-4):80-3. PubMed ID: 10932614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inter-alpha-trypsin inhibitor as precursor of the acid-stable proteinase inhibitors in human serum and urine.
    Hochstrasser K; Bretzel G; Feuth H; Hilla W; Lempart K
    Hoppe Seylers Z Physiol Chem; 1976 Feb; 357(2):153-62. PubMed ID: 3463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Otitis media and chronic middle ear effusion in the asthmatic pediatric patient.
    Gamble JE; Bizal JA; Daetwyler EP
    Ear Nose Throat J; 1992 Sep; 71(9):397-9. PubMed ID: 1425378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of toll-like receptors in chronic otitis media and cholesteatoma.
    Hirai H; Kariya S; Okano M; Fukushima K; Kataoka Y; Maeda Y; Nishizaki K
    Int J Pediatr Otorhinolaryngol; 2013 May; 77(5):674-6. PubMed ID: 23380629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Operative therapy for chronic otitis media and middle ear cholesteatoma with preservation of the posterior auditory canal wall ("intact wall technique") (author's transl)].
    Tos M
    HNO; 1978 Jul; 26(7):217-23. PubMed ID: 681183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mastocytes in chronic inflammation of middle ear mucosa].
    Sanković S; Dergenc R; Bojić P
    Srp Arh Celok Lek; 1999; 127(1-2):35-8. PubMed ID: 10377839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-gamma in suppurative otitis media: significance of otorrhoea type and disease outcome.
    Lasisi AO; Olayemi O; Arinola OG; Omilabu SA
    J Laryngol Otol; 2009 Oct; 123(10):1103-7. PubMed ID: 19640314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.